The Tumor Suppressor p53 in the Center of a Strategy Aiming at the Alleviation of Side Effects in Cancer Therapies.
Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg Martinistrasse 52, 20251 Hamburg (Germany).
L
Wiesmüller